Lixiana-H-C-002629-P46-012
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
variation-report
medication.label.permit_number
EMA/571616/2022
medication.label.permit_validity
First published: 2022-06-09T08:42:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live